Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Sonntag, 12.02.2012Börsentäglich über 11.000 News von 420 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

BIOSANTE PHARMACEUTICALS INC

WKN: 905841  ISIN: US09065V2034  Ticker-Symbol: BSF 
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
BIOSANTE PHARMACEUTICALS INC Chart 1 Jahr
1-Woche-Intraday-Chart
BIOSANTE PHARMACEUTICALS INC 1-Woche-Intraday-Chart

Aktuelle News zur BIOSANTE PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
10.02. 42
10.02. 119
NEW YORK, Feb. 9, 2012 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at BioSante Pharmaceuticals, Inc. ("BioSante" or the...
Mehr lesen zu:
Faruqi & Faruqi, LLP Announces Investigation of BioSante Pharmaceuticals, Inc.
09.02. 11
09.02. 3
09.02. 74
WASHINGTON (dpa-AFX) - BioSante Pharmaceuticals Inc. (BPAX) said the independent Data Monitoring Committee or DMC has completed the eighth unblinded review of the LibiGel Phase III cardiovascular...
Mehr lesen zu:
BioSante Pharma Reveals Positive LibiGel Safety Data For Phase III Program
09.02. 3
09.02. 1
09.02. 40
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the independent Data Monitoring Committee (DMC) has completed the eighth unblinded review of the LibiGel...
Mehr lesen zu:
BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review for Phase III Program
08.02. 12
08.02. 54
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the company has entered into a privately-negotiated securities exchange agreement with a holder of...
Mehr lesen zu:
BioSante Exchanges $5 Million Aggregate Principal Amount of Convertible Senior Notes for 6.7 Million Shares of Common Stock
08.02. 15
08.02. 86
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 6, 2012 to...
Mehr lesen zu:
Investor Alert: Kahn Swick & Foti, LLC and Partner Former Louisiana Attorney General Remind Investors With Large Financial Interests of Lead Plaintiff Deadline in Lawsuit Against BioSante Pharmaceuticals, Inc.
07.02. 12
07.02. 44
OKLAHOMA CITY, OK -- (Marketwire) -- 02/07/12 -- On February 3, 2012, a class action lawsuit was filed in the United States District Court for the Northern District of Illinois against BioSante Pharmaceuticals...
Mehr lesen zu:
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)
07.02. 36
HONG KONG -- (Marketwire) -- 02/07/12 -- This morning, www.MarketFoundations.com announced new reports highlighting Dendreon Corporation (NASDAQ: DNDN) and BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)....
Mehr lesen zu:
Perception, Opportunity in Volatility - Research & Analysis on Dendreon Corporation and BioSante Pharmaceuticals, Inc.
06.02. 31
06.02. 34
06.02. 40
Shareholder rights firm Robbins Umeda LLP, announces that the firm commenced a class action lawsuit on February 3, 2012 in the U.S. District Court for the Northern District...
Mehr lesen zu:
Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals, Inc.
01.02. 33
31.01. 87
NEW YORK, NY -- (Marketwire) -- 01/31/12 -- Biotechnology stocks have been on a tear this month, gaining an impressive 11 percent. Reuters recently released an article arguing health-care costs are...
Mehr lesen zu:
Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies / Five Star Equities Provides Stock Research on BioSante Pharmaceuticals & Cell Therapeutics
Seite: 1 2 3 Weiter>>
59 Nachrichten in den letzten 6 Monaten